Published in Am J Respir Crit Care Med on November 29, 2012
Adiposity and Airway Inflammation in HIV-Associated Airway Disease (SHOP) | NCT02975258
Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma. Am J Respir Crit Care Med (2013) 4.95
Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol (2016) 1.50
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther (2014) 0.90
Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children. Am J Respir Crit Care Med (2014) 0.89
Effect of antigen sensitization and challenge on oscillatory mechanics of the lung and pulmonary inflammation in obese carboxypeptidase E-deficient mice. Am J Physiol Regul Integr Comp Physiol (2014) 0.85
Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol (2014) 0.85
Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma. Mediators Inflamm (2015) 0.85
Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism. Toxicol Appl Pharmacol (2015) 0.85
Mitochondrial dysfunction in metabolic syndrome and asthma. J Allergy (Cairo) (2013) 0.84
Age at asthma onset and subsequent asthma outcomes among adults with active asthma. Respir Med (2013) 0.84
Data-driven asthma endotypes defined from blood biomarker and gene expression data. PLoS One (2015) 0.82
Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD). Int J Mol Sci (2014) 0.81
Obesity and extent of emphysema depicted at CT. Clin Radiol (2015) 0.80
Metabolic Syndrome Is Associated with Increased Oxo-Nitrative Stress and Asthma-Like Changes in Lungs. PLoS One (2015) 0.80
A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity. Respir Res (2015) 0.80
Arginine and nitric oxide pathways in obesity-associated asthma. J Allergy (Cairo) (2013) 0.78
Severe Asthma in Children: Lessons Learned and Future Directions. J Allergy Clin Immunol Pract (2016) 0.77
Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms. Mediators Inflamm (2016) 0.77
Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma. PLoS One (2014) 0.77
Mechanisms of Asthma in Obesity. Pleiotropic Aspects of Obesity Produce Distinct Asthma Phenotypes. Am J Respir Cell Mol Biol (2016) 0.77
Immunological characteristics and management considerations in obese patients with asthma. Expert Rev Clin Immunol (2015) 0.76
Emergence of Biomolecular Pathways to Define Novel Asthma Phenotypes. Type-2 Immunity and Beyond. Am J Respir Cell Mol Biol (2016) 0.76
Clinical asthma phenotyping: A trial for bridging gaps in asthma management. World J Clin Pediatr (2015) 0.76
Novel therapeutic strategies for adult obese asthmatics. Immunol Allergy Clin North Am (2014) 0.76
Clinical-biological phenotyping beyond inflammation in asthma delivers. Am J Respir Crit Care Med (2013) 0.76
Asthma and obesity: mechanisms and clinical implications. Asthma Res Pract (2015) 0.75
l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells. Clin Exp Allergy (2016) 0.75
Exhaled NO: Determinants and Clinical Application in Children With Allergic Airway Disease. Allergy Asthma Immunol Res (2015) 0.75
Metabolic origins of childhood asthma. Mol Cell Pediatr (2015) 0.75
Soft TCPTP Agonism-Novel Target to Rescue Airway Epithelial Integrity by Exogenous Spermidine. Front Pharmacol (2016) 0.75
Asthma management in sickle cell disease. Biomed Res Int (2013) 0.75
Effects of fetal exposure to high-fat diet or maternal hyperglycemia on L-arginine and nitric oxide metabolism in lung. Nutr Diabetes (2017) 0.75
Role of Obesity in Asthma: Mechanisms and Management Strategies. Curr Allergy Asthma Rep (2017) 0.75
Relationship of Oxidant and Antioxidant Markers to Asthma Severity in Egyptian Asthmatic Children. Open Access Maced J Med Sci (2017) 0.75
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17
Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med (2008) 5.80
Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol (2004) 2.80
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol (2011) 2.53
Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. Am J Physiol Lung Cell Mol Physiol (2006) 2.29
Molecular mechanisms of corticosteroid resistance. Chest (2008) 2.06
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet (2004) 1.71
The DDAH/ADMA/NOS pathway. Atheroscler Suppl (2003) 1.68
Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem (2002) 1.64
Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol (2011) 1.64
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr (2004) 1.60
Cluster analysis of obesity and asthma phenotypes. PLoS One (2012) 1.56
Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol (2007) 1.53
Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med (2008) 1.40
Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res (2007) 1.33
Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med (2011) 1.25
L-arginine increases exhaled nitric oxide in normal human subjects. Clin Sci (Lond) (1995) 1.22
Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol (2006) 1.19
Decreased fraction of exhaled nitric oxide in obese subjects with asthma symptoms: data from the population study INTERGENE/ADONIX. Chest (2010) 1.15
Determinants of exhaled breath condensate pH in a large population with asthma. Chest (2010) 1.12
Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. Am J Respir Cell Mol Biol (2008) 1.09
Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol (2010) 1.08
Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J Clin Endocrinol Metab (2006) 1.08
Measuring health-related quality of life in adults during an acute asthma exacerbation. Chest (2004) 1.06
Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. Am J Respir Cell Mol Biol (2009) 1.04
Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med (1996) 1.04
Corticosteroid resistance in airway disease. Proc Am Thorac Soc (2004) 1.04
Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men. Int J Cardiol (2010) 0.97
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome. Nitric Oxide (2011) 0.96
Obesity-asthma association: is it explained by systemic oxidant stress? Chest (2009) 0.94
L-arginine supplementation enhances exhaled NO, breath condensate VEGF, and headache at 4,342 m. High Alt Med Biol (2005) 0.93
Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity. Nutrition (2011) 0.89
Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. Am J Obstet Gynecol (2008) 0.89
Obesity and airway inflammation in asthma. J Allergy Clin Immunol (2006) 0.85
Changes in the arginine methylation of organ proteins during the development of diabetes mellitus. Diabetes Res Clin Pract (2011) 0.85
Effect of oral L-arginine on airway hyperresponsiveness to histamine in asthma. Thorax (1999) 0.85
Changes in exhaled nitric oxide after ingestion of L-arginine in children: a pilot study. Pediatr Pulmonol (2010) 0.83
Bronchodilator effect of inhaled nitric oxide in healthy men. Am J Respir Crit Care Med (1994) 0.82
Serum asymmetric dimethylarginine and nitric oxide levels in obese postmenopausal women. J Clin Lab Anal (2011) 0.81
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med (2013) 8.21
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA (2005) 6.14
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med (2003) 5.89
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet (2012) 5.82
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet (2003) 5.10
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet (2004) 5.01
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med (2014) 4.95
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med (2009) 4.83
Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med (2008) 4.70
Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med (2011) 4.68
High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr (2007) 4.61
Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med (2007) 4.58
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med (2007) 4.30
Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab (2007) 4.16
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med (2007) 4.11
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet (2008) 4.06
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med (2011) 3.80
Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68
Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol (2002) 3.66
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA (2008) 3.64
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest (2004) 3.63
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40
Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2007) 3.28
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA (2007) 3.25
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem (2002) 3.17
Nitric oxide in health and disease of the respiratory system. Physiol Rev (2004) 3.15
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14